Investigation and management of short stature
- 5 March 2014
- journal article
- review article
- Published by BMJ in Archives of Disease in Childhood
- Vol. 99 (8), 767-771
- https://doi.org/10.1136/archdischild-2013-304829
Abstract
Paediatricians need to develop a strategy for assessing and managing the short child because it is a common reason for referral to paediatric services. Understanding what is normal is a key prerequisite to the appropriate assessment of the short child. Most pathological causes of short stature will be associated with clues in the history or on examination. Factors that should trigger a more detailed assessment of the short child include malaise, dysmorphic features, slow growth and small size with a normal weight centile. Establishing that the healthy short child is growing appropriately for their family size can be reassuring for the family and clinician and will facilitate discharge.Keywords
This publication has 10 references indexed in Scilit:
- Pseudohypoparathyroidism: Diagnosis and TreatmentJournal of Clinical Endocrinology & Metabolism, 2011
- Indications for growth hormone therapy in childrenArchives of Disease in Childhood, 2011
- Short Stature due to SHOX Deficiency: Genotype, Phenotype, and TherapyHormone Research in Paediatrics, 2011
- Diagnosis of Growth Hormone DeficiencyEndocrine development, 2010
- The continuum of growth hormone–IGF‐I axis defects causing short stature: diagnostic and therapeutic challengesClinical Endocrinology, 2010
- The role of growth hormone in determining birth size and early postnatal growth, using congenital growth hormone deficiency (GHD) as a modelClinical Endocrinology, 2005
- The strengths and limitations of parental heights as a predictor of attained heightArchives of Disease in Childhood, 1999
- Intrauterine Growth Retardation and Postnatal Growth Failure Associated with Deletion of the Insulin-Like Growth Factor I GeneThe New England Journal of Medicine, 1996
- A new stress-related syndrome of growth failure and hyperphagia in children, associated with reversibility of growth-hormone insufficiencyThe Lancet, 1996
- Referral Criteria for Growth ScreeningJournal of Medical Screening, 1995